This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

AI x Next Generation Clinical Trials
April 22-23, 2026
Sheraton Boston HotelBoston, MA

Jennifer Goldsack
CEO at Digital Medicine Society (DiMe)
Speaker

Profile

Jennifer C. Goldsack is the founder and CEO of the Digital Medicine Society (DiMe), a 501(c)(3) non-profit dedicated to advancing digital medicine to optimize human health. Her work focuses on practical approaches to the safe, effective, and equitable use of digital technologies to improve health, healthcare, and health research.

Jennifer also brings the perspective of a patient navigating late-stage cancer, adding urgency and authenticity to her commitment to reshaping health care. She is a retired elite athlete – a Pan American Games champion, Olympian, and former world record holder.

She serves on the board of Sage Bionetworks, is a member of the National Academies of Sciences, Engineering, and Medicine’s Roundtable on Genomics and Precision Health, contributes to the World Economic Forum’s Digital Health Action Collaborative, and is an Executive Committee Member of the U.S. Department of Health and Human Services’ National Committee on Vital and Health Statistics (NCVHS).

She earned a master’s degree in chemistry from the University of Oxford, a master’s in the history and sociology of medicine from the University of Pennsylvania, and an MBA from the George Washington University.

Agenda Sessions

  • The Connected Trial: Designing with Downstream in Mind

    2:00pm